Patients encountering high deductibles regarding medication in their Affordable Care Act plans can seek assistance from drug manufacturers by using copay programs, said Daniel J. Klein, president and CEO of the Patient Access Network Foundation.
Patients encountering high deductibles regarding medication in their Affordable Care Act plans can seek assistance from drug manufacturers by using copay programs, said Daniel J. Klein, president and CEO of the Patient Access Network Foundation.
Transcript (modified)
What challenges are patients running into with Affordable Care Act plans?
The exchange plans, in some ways, look a lot like Medicare Part D, particularly around medications. I say this because exchange plans have, in many cases, a separate deductible for drugs and this deductible, whether it’s separate or not, is quite high. So I think the median deductible in the exchange silver plans is probably over $3000 annually.
The other thing that’s important to understand about the exchange plans is that they do have a maximum out-of-pocket limit, but oftentimes that doesn’t really kick in until around $6700 for an individual. If you’re above the subsidy level—what’s called the “cost-sharing reduction level”—within the exchange plans (and I think that’s about 250% of federal poverty level) then between that and the maximum out-of-pocket limit, between your deductibles and out-of-pocket costs until you hit that out-of-pocket limit, you may be unable to afford to use new treatments that are available. If you can’t find that $3000 plus whatever the coinsurance is it may be very difficult for you to get access to the care you need.
Now the important thing to understand is the difference in the exchange plans, that the drug manufacturers can provide direct assistance through their copay card program. Patients may be able to get assistance in that way.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More